Search results
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Average Recommendation of “Hold” by Brokerages
ETF DAILY NEWS· 6 days agoEnanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) has earned a consensus rating of “Hold” from the six ratings firms that are presently covering the firm, Marketbeat reports. One ...
GICAI launches revolutionary global digital currency quantitative trading platform to improve...
Digital Journal· 4 days agoShania Twain and Diamond-Selling Canadian Rockers Our Lady Peace to Headline Rogers...Presents the Advancement of LRP-661, Their Lead Drug Candidate, at ...
Aeterna Zentaris Announces Last Patient Last Visit in Pivotal DETECT-Trial for the Diagnosis of...
Digital Journal· 2 days agoAeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified ...
BetterLife Announces Closing of a Private Placement
Digital Journal· 20 hours agoBetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and ...